Aimed Alliance recently submitted a letter to the Tennessee legislature in support of House Bill 484, which would require Tennessee health plans to cover biomarker testing when supported by medical and scientific evidence. This legislation represents a crucial step in advancing personalized medicine and ensuring patients have access to the most effective diagnostic and treatment options available. By ensuring that health plans cover biomarker testing when backed by scientific evidence, policymakers can help drive innovation, improve patient care, and outcomes Read the letter here.
Last Updated on March 21, 2025 by Aimed Alliance
